Quantcast
Don't Miss
Home / Columns / Commentary: Litigation over Takeda’s diabetes drug Actos reaches crossroads

Commentary: Litigation over Takeda’s diabetes drug Actos reaches crossroads

Scientific studies and action from the Food and Drug Administration linking diabetes drug Actos to bladder cancer have resulted in lawsuits filed across the country against Actos’ Japanese manufacturer, Takeda.

Order Reprints

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

 

Scroll To Top